Cargando…

miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1

Melanoma is an aggressive malignancy with a high metastatic potential. microRNA-17 (miR-17) is a member of the oncogenic miR-17/92 cluster. Here we study the effect of miR-17 on melanoma cell motility. Over expression of the mature or pri-microRNA form of miR-17 in WM-266-4 and 624mel melanoma lines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Ronit, Greenberg, Eyal, Nemlich, Yael, Schachter, Jacob, Markel, Gal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662471/ https://www.ncbi.nlm.nih.gov/pubmed/26158900

Ejemplares similares

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex
por: Greenberg, Eyal, et al.
Publicado: (2014)

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs
por: Greenberg, Eyal, et al.
Publicado: (2011)

Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells()()
por: Kfir-Elirachman, Karin, et al.
Publicado: (2018)

ADAR1-mediated regulation of melanoma invasion
por: Nemlich, Yael, et al.
Publicado: (2018)

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
por: Galore-Haskel, Gilli, et al.
Publicado: (2015)

Mutagen-Specific Mutation Signature Determines Global microRNA Binding
por: Greenberg, Eyal, et al.
Publicado: (2011)

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours
por: Gits, C M M, et al.
Publicado: (2013)

SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells
por: Ashkenazi, Shira, et al.
Publicado: (2016)

CEACAM1 Promotes Melanoma Cell Growth through Sox-2()()
por: Ortenberg, Rona, et al.
Publicado: (2014)

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma
por: Itzhaki, Orit, et al.
Publicado: (2013)

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
por: Asher, Nethanel, et al.
Publicado: (2020)

miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2017)

Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms
por: Sapoznik, Sivan, et al.
Publicado: (2012)

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
por: Asher, Nethanel, et al.
Publicado: (2021)

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
por: Sivan, Sapoznik, et al.
Publicado: (2012)

miR-129-5p inhibits prostate cancer proliferation via targeting ETV1
por: Gao, Ge, et al.
Publicado: (2019)

90. Fecal Microbiota Transplantation in Metastatic Melanoma Patients Resistant to Anti-PD-1 Treatment
por: Youngster, Ilan, et al.
Publicado: (2019)

Differential Sensitivity of Target Genes to Translational Repression by miR-17~92
por: Jin, Hyun Yong, et al.
Publicado: (2017)

Etv2-miR-130a-Jarid2 cascade regulates vascular patterning during embryogenesis
por: Singh, Bhairab N., et al.
Publicado: (2017)

A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
por: Guo, Chunmei, et al.
Publicado: (2020)

Suppression of RNA editing by miR-17 inhibits the stemness of melanoma stem cells
por: Zhang, Yu, et al.
Publicado: (2021)

Correction to: A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
por: Guo, Chunmei, et al.
Publicado: (2021)

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies
por: Besser, Michal J., et al.
Publicado: (2013)

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma
por: Galore-Haskel, Gilli, et al.
Publicado: (2017)

Biological role of miR-204 and miR-211 in melanoma
por: Vitiello, Marianna, et al.
Publicado: (2018)

Epigenetic Regulation of MicroRNA Genes and the Role of miR-34b in Cell Invasion and Motility in Human Melanoma
por: Mazar, Joseph, et al.
Publicado: (2011)

miR-34a Regulates Sperm Motility in Zebrafish
por: Guo, Wenjie, et al.
Publicado: (2017)

Circular RNA hsa_circ_0001666 sponges miR-330-5p, miR-193a-5p and miR-326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4
por: Qi, Ying, et al.
Publicado: (2021)

miR-17 acts as a tumor suppressor by negatively regulating the miR-17-92 cluster
por: Sweat, Yan, et al.
Publicado: (2021)

SRSF3 shapes the structure of miR‐17‐92 cluster RNA and promotes selective processing of miR‐17 and miR‐20a
por: Ratnadiwakara, Madara, et al.
Publicado: (2023)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging
por: Hackl, Matthias, et al.
Publicado: (2010)

miR614 Expression Enhances Breast Cancer Cell Motility
por: Dang, Tuyen T., et al.
Publicado: (2020)

Expression and predictive value of miR-489 and miR-21 in melanoma metastasis
por: Mo, Hao, et al.
Publicado: (2019)

MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion
por: Ast, Volker, et al.
Publicado: (2018)

Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5
por: Currie, Simon L., et al.
Publicado: (2017)

MiR-17 and miR-19 cooperatively promote skeletal muscle cell differentiation
por: Kong, Delin, et al.
Publicado: (2019)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
por: Xu, Y, et al.
Publicado: (2012)

miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110
por: Song, Rui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_68s45s5lnv8q8sffl0kbd8p9j1